Quipt Home Medical (NASDAQ:QIPT - Get Free Report) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Monday, May 12th. Analysts expect Quipt Home Medical to post earnings of $0.02 per share and revenue of $88.29 million for the quarter.
Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last posted its earnings results on Monday, February 10th. The company reported ($0.03) EPS for the quarter. Quipt Home Medical had a negative net margin of 2.90% and a negative return on equity of 6.70%. On average, analysts expect Quipt Home Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Quipt Home Medical Stock Performance
Shares of QIPT traded up $0.01 during mid-day trading on Monday, reaching $2.18. The company had a trading volume of 30,313 shares, compared to its average volume of 194,643. The company has a quick ratio of 0.87, a current ratio of 1.22 and a debt-to-equity ratio of 0.74. Quipt Home Medical has a 52-week low of $1.86 and a 52-week high of $4.17. The stock has a market capitalization of $93.94 million, a P/E ratio of -12.82 and a beta of 0.65. The stock has a 50 day moving average of $2.25 and a two-hundred day moving average of $2.60.
About Quipt Home Medical
(
Get Free Report)
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Quipt Home Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.
While Quipt Home Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
